News
Sepsis survivors’ persistent immunosuppression raises mortality risk
August 7, 2019
Individuals with persistent biomarkers of inflammation and immunosuppression had a higher risk of readmission and death because of cardiovascular disease.
News
Dispatch from HM19: COPD updates
August 2, 2019
Every COPD exacerbation is associated with economic, social, and mortality burdens.
News
Enteral feeding is safe during bronchiolitis HFNC
August 2, 2019
SEATTLE – Parents feel better when they know their children are “getting food in their belly.”
News
Short-course azithromycin no benefit in pediatric asthma admissions
July 31, 2019
SEATTLE – Clinicians should consider these data before prescribing azithromycin to children hospitalized with asthma.
News
New analysis challenges fluid resuscitation guidelines for patients in shock
July 17, 2019
For children in shock, fluid resuscitation has counterproductive effects on respiratory and neurologic function.
News
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
July 11, 2019
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
News
C-reactive protein testing reduced antibiotic prescribing in patients with COPD exacerbation
July 10, 2019
Fewer prescriptions, less reported antibiotic use, with no evidence of harm or reduced quality of life, according to PACE trial investigators.
News
No reduction in PE risk with vena cava filters after severe injury
July 9, 2019
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in patients who can be treated with prophylactic anticoagulation within 7 days after injury,” the investigators wrote.
News
Study: Most patients hospitalized with pneumonia receive excessive antibiotics
July 8, 2019
Odds of adverse events increased by 5% per excess day of antibiotic treatment.
News
Risk of cardiac events jumps after COPD exacerbation
July 2, 2019
Acute COPD exacerbations are associated with an increased risk of major adverse cardiac events in the 4 weeks after the exacerbation.